Mediera Corporation

NT$15.85As of Sun 8 Nov 2026, 12:00 UTC
TPEx:5398Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (10.15%)
Div yield —
ROE 0.92%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.33)
PE TTM 160.9
TSR TTM (17.02%)
Mkt cap NT$784.0M
ROIC (0.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$20
26.50%
58.53%
Hold 9|0|10|3|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.16
0.16
0.16
0.16
13.97%
(0.38%)
1.68%
(2.40%)
RevenueNT$M
69.45
71.45
73.40
71.96
7.45%
9.66%
9.69%
2.79%
Peers (US$23.68M)
Cap (US$)
PE
25.59M
11.06x
Capital
TTM
5Y
10Y
Leveragex
1.944
(0.556)
(0.388)
EBIT/Intx
0.801
0.214
0.249
Own earn%
(17.49)
(50.78)
(52.06)
Sh yield%
34.13
41.59
43.25
Owners
Insiders/Inst%
11.19
47.99
Short interest%
3.27
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
12